Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Obesity-associated inflammation can accelerate NAD turnover through PARP-1 and CD38 pathways [85, 97, 116]
Medications such as Ozempic, Wegovy, and Mounjaro have brought GLP-1 into the spotlight by mimicking this natural hormone to improve metabolic control
Here is a list of some commonly prescribed GLP-1 agonists: Ozempic (semaglutide) Wegovy (semaglutide) Mounjaro (tirzepatide) Byetta (exenatide) Victoza (liraglutide) Trulicity (dulaglutide) Tanzeum (albiglutide) Rybelsus (semaglutide) Adlyxin (lixisenatide) Dulaglutide XL GLP-1 agonists are commonly prescribed for the treatment of type 2 diabetes and weight management, as they have been shown to help lower blood sugar levels and promote weight loss
Eli Lilly's self-pay vial program (LillyDirect) offers lower single-dose vials, often in the $349 to $499 range depending on dose
Ozempic costs $11,971 per year if you don't have insurance or if your insurance won't cover your prescription
US$ 28.46
US$ 27.47
US$ 28.02
